Contrast agent for photoacoustic imaging and photoacoustic imaging method utilizing same
A photoacoustic imaging and contrast agent technology, which can be applied to preparations for in vivo experiments, medical preparations without active ingredients, and medical preparations containing active ingredients, etc., which can solve the problem of low sensitivity of contrast media and low absorption coefficient of contrast media and other problems to achieve the effect of high antigen binding performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0084] Hereinafter, embodiments of the present invention will be described with reference to the drawings and the like. These embodiments individually disclose examples of the contrast agent for photoacoustic imaging of the present invention and photoacoustic imaging using the contrast agent. The technical scope of the present invention is not limited to them.
no. 1 Embodiment approach
[0086] The contrast agent for photoacoustic imaging according to the first embodiment is represented by Formula 1, and includes: particles containing iron oxide particles that absorb light in the near-infrared region; and at least one or more particles immobilized on the particles containing iron oxide particles. The ligand molecule, wherein the ligand molecule is immobilized at a density equal to or greater than the cell surface density of the target molecule.
[0087] MNP-((L) l -(P) m ) n (Formula 1), wherein MNP represents a particle containing iron oxide particles; L represents a linker molecule; P represents a ligand molecule; l represents 0 or 1; and m and n represent integers of 1 or greater.
[0088] The contrast agent for photoacoustic imaging of the present embodiment has been realized by paying attention to the high absorption coefficient in the near-infrared region of the particles containing iron oxide particles. The contrast agent is characterized in that: th...
no. 2 Embodiment approach
[0142] (iron oxide particle-containing particle with HER2-binding single-chain antibody)
[0143] The second embodiment of the present invention includes a compound represented by Formula 2, which has: particles containing iron oxide particles; and at least one or more epidermal growth factor receptor 2 (HER2)-binding single-chain antibody (scFv).
[0144] MNP-(-(L) l -(P) m ) n (Formula 2), wherein MNP represents particles containing iron oxide particles; L represents linker molecules; P represents epidermal growth factor receptor 2 (HER2)-binding single-chain antibody (scFv); l represents 0 or 1; and m and n Represents an integer of 1 or greater.
[0145]The compounds can be used as contrast agents for photoacoustic imaging according to the invention and as contrast agents for magnetic resonance imaging (MRI). In addition, compounds with ferromagnetic or paramagnetic particles containing iron oxide particles can be used for magnetic separation or purification of HER2 by ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com